Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Web site
Administrative institutions
Université de Lille
CHU Lille
Inserm
Recent Submissions
-
Human ovarian extracellular vesicles proteome from polycystic ovary syndrome patients associate with follicular development alterations
Faseb J., 18-11-2024, 38, -Article dans une revue scientifique -
Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities.
Cell Death Dis, 07-12-2024, 15, 879Article dans une revue scientifique -
Heterogeneity Assessment and Protein Pathway Prediction via Spatial Lipidomic and Proteomic Correlation: Advancing Dry Proteomics concept for Human Glioblastoma Prognosis.
Mol Cell Proteomics, 14-12-2024, 100891Article dans une revue scientifique -
Protocol for generating a co-culture of macrophages with breast cancer tumoroids.
STAR Protoc, 28-12-2024, 6, 103536Article dans une revue scientifique -
Microsurgical management of recurrent intracranial aneurysm after endovascular treatment: a series of 60 consecutive patients.
Journal of Neurosurgery, 28-06-2024, 141, 1235–1243Article dans une revue scientifique -
Complex abdominal wall reconstruction for an isolated parietal recurrence of ovarian cancer.
Int J Gynecol Cancer, 23-11-2023Article dans une revue scientifique -
Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
Eur J Surg Oncol, 15-02-2024, 50, 107976Article dans une revue scientifique -
Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.
Front Oncol, 05-04-2024, 14, 1347727Article dans une revue scientifique -
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial.
Ann Surg Oncol, 16-04-2024Article dans une revue scientifique -
Intermediate-risk endometrial cancer treated with adjuvant brachytherapy using single dosimetric planning: long-term outcome and toxicity assessment.
Eur J Obstet Gynecol Reprod Biol, 06-05-2024, 298, 23-30Article dans une revue scientifique